CHRN
Ekso Bionics Holdings, Inc. Common Stock
NASDAQ · Healthcare · Medical - Specialties · US
$15.76
+5.28%Research · Sep 16, 2026
[CHRN] ChronoScale: Can a One-Customer GPU Cloud Hold Its Revenue Run Rate?
ChronoScale's fiscal 2026 produced $71.604 million of revenue against $88.691 million of cost of revenues; the 2026-09-21 report is the first read on whether the renewed Together AI rate held.